Skip to main content
. 2021 Dec;12(6):2788–2802. doi: 10.21037/jgo-21-655

Figure 4.

Figure 4

Evaluation of the XMG prognostic model. (A,B) Kaplan-Meier survival curves of low- and high-risk groups of colon cancer patients. (C,D) Heatmap of expression levels of XMGs involved in prognostic model in low- and high-risk groups of colon cancer patients. (E,F) Risk score distribution in low- and high-risk groups of colon cancer patients. (G,H) Survival status distribution in low- and high-risk groups of colon cancer patients. (I,J) Mortality in low- and high-risk groups of colon cancer patients. XMG, xenobiotic metabolism gene.